We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RERE:NYSEATRenew Inc. Analysis

Data as of 2026-07-23 - not real-time

$3.79

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

ATRenew Inc. (RERE) is trading at $3.79, well below its 20‑day ($3.94), 50‑day ($4.19) and 200‑day ($4.78) simple moving averages, signaling a bearish technical backdrop. The RSI of 42 suggests the stock is not yet oversold, while a bearish MACD and decreasing volume reinforce short‑term downside pressure. Volatility is elevated at roughly 49% over the past 30 days and a computed beta of 1.46 indicates the stock moves more aggressively than the market, amplifying risk. On the fundamentals side, revenue surged 32% year‑over‑year to $22.6 bn, yet margins remain thin (gross 20.6%, operating 3%) and operating/free cash flow is effectively zero, raising concerns about cash generation. Debt‑to‑equity is high at over 9, though total debt is modest relative to cash on hand, and the dividend payout of 39% of earnings may be strained without cash flow support. Analysts rate the stock as a strong buy with a mean target of $7.05, implying an 86% upside, and the market sentiment index reads “Extreme Greed,” reflecting strong investor appetite despite the technical weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below all major SMAs indicating bearish momentum
  • Decreasing volume and bearish MACD histogram
  • High short‑term volatility and beta

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of 32% and forward PE of ~6x
  • Target price median of $7.34 suggesting >80% upside
  • Attractive price‑to‑sales (0.04) and price‑to‑book (1.58) multiples

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strategic position in China's growing pre‑owned electronics market
  • Undervalued valuation relative to long‑term earnings potential
  • Analyst consensus of strong‑buy and sustained dividend yield

Key Metrics & Analysis

Financial Health

Revenue Growth32.40%
Profit Margin1.90%
P/E Ratio14.6
ROE11.15%
ROA6.27%
Debt/Equity9.12
P/B Ratio1.6

Technical Analysis

TrendBearish
RSI42.3
Support$3.70
Resistance$4.32
MA 20$3.94
MA 50$4.19
MA 200$4.78
MACDBearish
VolumeDecreasing
Fear & Greed Index86.64

Valuation

Target Price$7.05
Upside/Downside86.11%
GradeUndervalued
TypeBlend
Dividend Yield2.61%

Risk Assessment

Beta1.46
Volatility49.35%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.